182 related articles for article (PubMed ID: 26096783)
1. Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.
Nishikawa R; Chiyomaru T; Enokida H; Inoguchi S; Ishihara T; Matsushita R; Goto Y; Fukumoto I; Nakagawa M; Seki N
FEBS Lett; 2015 Jul; 589(16):2136-45. PubMed ID: 26096783
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
Qu Y; Xiao H; Xiao W; Xiong Z; Hu W; Gao Y; Ru Z; Wang C; Bao L; Wang K; Ruan H; Song Z; Chen K; Zhang X; Yang H
Cell Physiol Biochem; 2018; 48(3):1075-1087. PubMed ID: 30041179
[TBL] [Abstract][Full Text] [Related]
3. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
Kurozumi A; Kato M; Goto Y; Matsushita R; Nishikawa R; Okato A; Fukumoto I; Ichikawa T; Seki N
Int J Oncol; 2016 May; 48(5):1837-46. PubMed ID: 26983694
[TBL] [Abstract][Full Text] [Related]
5. Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.
Kato M; Kurozumi A; Goto Y; Matsushita R; Okato A; Nishikawa R; Fukumoto I; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2017 Jan; 62(1):123-132. PubMed ID: 27278788
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.
Fukumoto I; Kikkawa N; Matsushita R; Kato M; Kurozumi A; Nishikawa R; Goto Y; Koshizuka K; Hanazawa T; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2016 Feb; 61(2):109-18. PubMed ID: 26490187
[TBL] [Abstract][Full Text] [Related]
7. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
[TBL] [Abstract][Full Text] [Related]
8. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
Kinoshita T; Nohata N; Hanazawa T; Kikkawa N; Yamamoto N; Yoshino H; Itesako T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2013 Nov; 109(10):2636-45. PubMed ID: 24091622
[TBL] [Abstract][Full Text] [Related]
9. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
10. LOXL2 status correlates with tumor stage and regulates integrin levels to promote tumor progression in ccRCC.
Hase H; Jingushi K; Ueda Y; Kitae K; Egawa H; Ohshio I; Kawakami R; Kashiwagi Y; Tsukada Y; Kobayashi T; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
Mol Cancer Res; 2014 Dec; 12(12):1807-17. PubMed ID: 25092917
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.
Qi Y; Ma Y; Peng Z; Wang L; Li L; Tang Y; He J; Zheng J
Oncogene; 2020 May; 39(22):4404-4420. PubMed ID: 32341409
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals.
Wang K; Sun Y; Tao W; Fei X; Chang C
Cancer Lett; 2017 May; 394():1-12. PubMed ID: 28089832
[TBL] [Abstract][Full Text] [Related]
13. Re: Tumour-Suppressive MicroRNA-29s Directly Regulate LOXL2 Expression and Inhibit Cancer Cell Migration and Invasion in Renal Cell Carcinoma.
Atala A
J Urol; 2016 May; 195(5):1622. PubMed ID: 27186784
[No Abstract] [Full Text] [Related]
14. Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.
Kamikawaji K; Seki N; Watanabe M; Mataki H; Kumamoto T; Takagi K; Mizuno K; Inoue H
J Hum Genet; 2016 Dec; 61(12):985-993. PubMed ID: 27488440
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.
Mizuno K; Seki N; Mataki H; Matsushita R; Kamikawaji K; Kumamoto T; Takagi K; Goto Y; Nishikawa R; Kato M; Enokida H; Nakagawa M; Inoue H
Int J Oncol; 2016 Feb; 48(2):450-60. PubMed ID: 26676674
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.
Nishikawa R; Goto Y; Kojima S; Enokida H; Chiyomaru T; Kinoshita T; Sakamoto S; Fuse M; Nakagawa M; Naya Y; Ichikawa T; Seki N
Int J Oncol; 2014 Jul; 45(1):401-10. PubMed ID: 24820027
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
Yamasaki T; Seki N; Yoshino H; Itesako T; Yamada Y; Tatarano S; Hidaka H; Yonezawa T; Nakagawa M; Enokida H
Cancer Sci; 2013 Nov; 104(11):1411-9. PubMed ID: 23889809
[TBL] [Abstract][Full Text] [Related]
18. miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.
Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W
Urol Int; 2021; 105(9-10):906-915. PubMed ID: 34192708
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional role of miR-29b in renal cell carcinoma.
Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
